Drugs / iNSC-EV01
last change Oct 2025 re-read 3 minutes ago

iNSC-EV01

Other / unclassified

Developed for
ischemic stroke
Investigated by
Wiseheart Co.Ltd · Xuanwu Hospital, Beijing

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT07143786 Oct 2025 → Jul 2027 expected ischemic stroke Xuanwu Hospital, Beijing Not yet recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as iNSC-EV01 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07143786 ↗
Modality Other / unclassified “Intravenous induced neural stem cell-derived exosome” NCT07143786 ↗
Route Intravenous “Intravenous induced neural stem cell-derived exosome” NCT07143786 ↗